Fatty liver disease is often discovered almost by accident.
A routine blood test comes back abnormal. An ultrasound shows excess fat in the liver. Or a doctor mentions it during a checkup—even though you feel perfectly fine.
That is part of what makes fatty liver so easy to underestimate.
The condition now commonly called metabolic dysfunction-associated steatotic liver disease (MASLD)—previously known as non-alcoholic fatty liver disease or NAFLD—often causes few or no obvious symptoms. Yet growing evidence suggests its effects may extend far beyond the liver.
One organ attracting particular attention is the kidney.
Recent research suggests that people with fatty liver disease are more likely to develop chronic kidney disease, especially when liver fibrosis, diabetes, obesity, high blood pressure, or other metabolic problems are also present.
So the question is no longer simply:
“How healthy is your liver?”
It may also be:
“What is your liver telling you about the health of the rest of your body?”
What Exactly Is Fatty Liver Disease?
Your liver naturally contains some fat.
The problem begins when excessive fat accumulates inside liver cells.
MASLD describes fatty liver occurring alongside metabolic risk factors such as insulin resistance, obesity, type 2 diabetes, abnormal cholesterol or triglycerides, and related metabolic dysfunction.
For many people, the condition remains relatively mild.
Others develop a more aggressive form called metabolic dysfunction-associated steatohepatitis, or MASH, in which fat accumulation is accompanied by inflammation and liver-cell injury.
Over time, repeated inflammation can lead to fibrosis, or scar tissue.
Advanced fibrosis can eventually progress to cirrhosis, liver failure, or liver cancer.
But researchers are increasingly recognizing that the liver does not operate in isolation.
The Liver and Kidneys Are More Connected Than You Think
Your liver and kidneys perform different jobs, but both are deeply involved in metabolism and blood chemistry.
The liver helps regulate:
- blood sugar
- cholesterol and triglycerides
- hormone metabolism
- protein production
- nutrient processing
- detoxification pathways
Your kidneys regulate:
- fluid balance
- electrolyte levels
- blood pressure
- waste removal
- acid-base balance
When metabolic health begins to deteriorate, both organs may be affected.
That helps explain why fatty liver disease and chronic kidney disease frequently appear together.
A recent systematic review and meta-analysis of longitudinal studies found an association between MASLD/NAFLD and the later development of chronic kidney disease.
Importantly, researchers are still working out exactly how much of this relationship comes directly from fatty liver and how much comes from the conditions that often accompany it.
The Shared Metabolic Problem
One major connection is insulin resistance.
When cells stop responding efficiently to insulin, the pancreas must produce more of it to keep blood sugar under control.
At the same time, more fatty acids may circulate through the bloodstream and accumulate in the liver.
This can contribute to:
- fatty liver
- higher triglycerides
- increased blood pressure
- type 2 diabetes
- vascular damage
All of these can also place additional strain on the kidneys.
In fact, diabetes and high blood pressure remain two of the most important causes of chronic kidney disease.
Fatty liver may therefore act as an early warning that the body’s metabolic system is already under significant stress.
Inflammation May Be Part of the Connection
Fat accumulation in the liver does more than simply occupy space.
In some people, it triggers inflammatory signaling.
When liver cells become stressed or damaged, they can release inflammatory molecules into circulation.
Researchers believe chronic low-grade inflammation, oxidative stress, changes in fat metabolism, and vascular dysfunction may all contribute to the association between fatty liver and kidney disease.
This does not mean fatty liver directly “poisons” the kidneys.
The biology is much more complex.
Instead, both organs appear to participate in an interconnected network involving metabolism, blood vessels, hormones, inflammation, and insulin sensitivity.
Why Liver Fibrosis Matters
Not everyone with a fatty liver has the same level of risk.
The presence of fibrosis appears especially important.
Fibrosis means that repeated liver injury has begun replacing normal tissue with scar tissue.
The more advanced the fibrosis, the greater the concern about long-term liver complications.
Research also suggests that people with more advanced metabolic liver disease often experience greater cardiovascular and kidney risk.
That is one reason simply knowing you “have fatty liver” is not always enough.
Doctors may need to evaluate whether fibrosis is present and how advanced it may be.
Fatty Liver Is Often Silent
This is one of the biggest problems with MASLD.
You can have significant liver fat without knowing it.
According to the NIDDK, many people with fatty liver disease experience few or no symptoms. When symptoms do occur, they may include fatigue or discomfort in the upper-right portion of the abdomen.
Kidney disease can also develop quietly.
Testing may therefore reveal problems long before symptoms appear.
Depending on individual risk factors, physicians may assess:
- liver enzymes
- blood glucose
- HbA1c
- cholesterol and triglycerides
- blood pressure
- creatinine
- estimated glomerular filtration rate (eGFR)
- urine albumin
- liver imaging
People with diabetes, high blood pressure, cardiovascular disease, or a family history of kidney failure are particularly encouraged to undergo appropriate kidney screening.
Can Fatty Liver Be Improved?
In many people, yes—especially when addressed before advanced fibrosis develops.
Lifestyle changes remain a cornerstone of treatment.
1. Reduce Excess Body Weight Gradually
For people who are overweight, even relatively modest weight loss can reduce liver fat.
The NIDDK notes that losing approximately 3% to 5% of body weight may reduce liver fat, while larger reductions may be necessary to improve inflammation and fibrosis.
Crash dieting is not the answer.
Gradual, sustainable change is preferable.
2. Cut Back on Added Sugar
Sugary beverages are particularly easy to overconsume.
Sodas, sweetened teas, energy drinks, and other sugar-rich drinks can contribute large amounts of rapidly absorbed sugar without providing much satiety.
The NIDDK specifically recommends limiting foods and beverages containing large amounts of simple sugars, particularly fructose-rich sweetened drinks.
3. Build Meals Around Whole Foods
A liver-friendly eating pattern does not need to involve exotic detoxes.
Focus on foods such as:
- vegetables
- legumes
- berries and whole fruits
- whole grains
- nuts and seeds
- fish
- olive oil
- minimally processed proteins
Replacing saturated and trans fats with healthier unsaturated fats may also benefit overall metabolic and cardiovascular health.
4. Move Regularly
Exercise can improve insulin sensitivity and metabolic health.
Importantly, physical activity may benefit fatty liver even when dramatic weight loss does not occur.
Walking, resistance training, cycling, swimming, and other sustainable forms of movement can all contribute.
5. Control Blood Pressure and Blood Sugar
This may be just as important for kidney protection as it is for liver health.
Because diabetes and hypertension are major drivers of kidney disease, controlling them can dramatically influence long-term risk.
Be Careful With “Liver Detox” Supplements
This is where natural-health advice sometimes becomes counterproductive.
A product labeled “liver cleanse” is not automatically good for the liver.
Some concentrated herbal supplements have been associated with liver injury.
The NIDDK specifically advises discussing supplements and complementary medicines with a healthcare professional because certain herbal remedies may damage the liver.
Food-based support—vegetables, fiber-rich foods, herbs used normally in cooking, adequate hydration, exercise, and metabolic control—is very different from taking high-dose extracts.
Treatment Is Changing Too
Medical treatment for more advanced forms of fatty liver disease has evolved significantly.
In 2024, the FDA approved resmetirom (Rezdiffra) alongside diet and exercise for certain adults with noncirrhotic MASH and moderate-to-advanced fibrosis.
In August 2025, the FDA also approved semaglutide (Wegovy) for adults with MASH and moderate-to-advanced liver fibrosis.
These medicines are intended for specific patients and are not necessary or appropriate for everyone with fatty liver.
But their approval reflects an important change: fatty liver disease is increasingly being treated as a serious metabolic condition rather than a harmless incidental finding.
The Bigger Message
Fatty liver is not simply “fat sitting in the liver.”
It can be a sign that insulin regulation, blood fats, blood pressure, inflammation, and overall metabolic health are moving in the wrong direction.
And because the kidneys rely on healthy blood vessels, blood pressure, and glucose regulation, they may eventually become part of the same metabolic story.
That does not mean everyone with fatty liver will develop kidney disease.
But it does mean fatty liver should not automatically be dismissed simply because there are no symptoms.
Sometimes the earliest warning from your liver is not pain.
It is the discovery that your metabolism needs attention—before another organ begins showing signs of trouble.
